EMAIL THIS PAGE TO A FRIEND

Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion

[The medical management of Cushing's syndrome].


PMID 19627735

Abstract

Cushing's syndrome results from prolonged exposure to excessive circulating glucocorticosteroids and is associated with significant morbidity and mortality. While the treatment of choice in most patients is surgical, the metabolic consequences of this syndrome, including hypertension and diabetes mellitus, increase the risks of such surgery. Hypercortisolemia and its sequelae can be efficiently reversed or controlled using medical therapy, either as a temporary measure prior to definitive treatment or as a longer-term treatment in some particularly difficult cases. Drug treatment has been targeted at the hypothalamic/pituitary level, the adrenal glands and at glucocorticoid receptors. The present review discusses the pharmacotherapeutic agents that have been used in Cushing's syndrome and the criteria for their use, as well as recent drugs that may improve the medical treatment of this complex endocrinological disorder in the future. Finally, the short-and long-term follow-up of patients with Cushing's syndrome after surgery is also discussed.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

A9657
DL-Aminoglutethimide
C13H16N2O2